| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/30/2004 | US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents |
| 09/30/2004 | US20040192632 comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with the Non-Immunogenic or High Molecular Weight Compound |
| 09/30/2004 | US20040192611 amino acid sequence GVAWWM*; and GVAWWM*Y; wherein M* is methionine sulfoxide; use reducing oxidative degradation of fats or oils, or providing an antioxidant to a person in either pharmaceutical or dietary compositions |
| 09/30/2004 | US20040192610 For treating disorders regulated at neuronal nicotinic acetylcholine receptors, including cardiovascular disorders, gastric motility disorders, urinary incontinence, nicotine addiction, mood disorders and small cell lung carcinoma |
| 09/30/2004 | US20040192609 Peptides binding gp120 of HIV-1 |
| 09/30/2004 | US20040192608 Treatment of obesity |
| 09/30/2004 | US20040192607 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 09/30/2004 | US20040192605 Methods and compositions for healing and repair of articular cartilage |
| 09/30/2004 | US20040192602 Comprises enhanced blood protein with for use in treatment of bleeding disorders |
| 09/30/2004 | US20040192601 Lipid binding molecules and methods of use |
| 09/30/2004 | US20040192599 Gene therapy for hemophilia a |
| 09/30/2004 | US20040192597 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer |
| 09/30/2004 | US20040192596 Therapeutic fibrin-derived peptides and uses thereof |
| 09/30/2004 | US20040192593 Protease resistant ti-growth hormone releasing hormone |
| 09/30/2004 | US20040192589 Production of high molecular mass lectins |
| 09/30/2004 | US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/30/2004 | US20040191912 New constitutive plant promoter |
| 09/30/2004 | US20040191911 Method for altering degradation of engineered protein in plant cells |
| 09/30/2004 | US20040191910 Genes encoding plant transcription factors |
| 09/30/2004 | US20040191902 Generating hepatocyte-like cell; provide stem cells, inoculate with cytokines and hepatocyte growth factor mixture, culture and recover cells; tissue engineering |
| 09/30/2004 | US20040191899 Method for disrupting cells that lack a cell wall |
| 09/30/2004 | US20040191887 Comprises nucleotide sequences coding synaptotagmin membrane proteins for diagnosis, treatment and prevention of botulinum neurotoxicity |
| 09/30/2004 | US20040191886 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins |
| 09/30/2004 | US20040191884 Photoprotein derived from okinawan squid and gene encoding the photoprotein |
| 09/30/2004 | US20040191877 lovE variant regulator molecules |
| 09/30/2004 | US20040191868 Nucleotide sequence coding canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals |
| 09/30/2004 | US20040191866 Attenuated microorganisms for the treatment of infection |
| 09/30/2004 | US20040191865 Using transgenic cells for propagation of heterologous proteins; bioreactors |
| 09/30/2004 | US20040191864 Methods for producing biological substances in enzyme-deficient mutants of Aspergillus |
| 09/30/2004 | US20040191862 Chimeric g-protein coupled receptor for use as tool in high throughput assays which screen/identify modulators of sweet taste; artificial sweetners; enhancing consumability/flavor of animal feeds |
| 09/30/2004 | US20040191860 150 Kda accessory receptor for tgf-beta |
| 09/30/2004 | US20040191857 Process for the preparation of angiotensis converting enzyme (ACE) inhibitors and its use |
| 09/30/2004 | US20040191851 Methods for the identification of inhibitors of lipid transfer protein activity in plants |
| 09/30/2004 | US20040191850 Nucleic acid molecules encoding proteins essential for plant growth and development and uses thereof |
| 09/30/2004 | US20040191845 Designed protein pores as components for biosensors |
| 09/30/2004 | US20040191840 Using immunoglobulins to inactivate viricidal and antitumor activities of huma n type interferon for preventing autoimmunity and graft rejection; immunosuppressants |
| 09/30/2004 | US20040191832 Avidin derivatives and uses thereof |
| 09/30/2004 | US20040191829 Comprises peptide associated with sugar transport protein for identifying modulators for treatment and prevention of cell proliferative disorder |
| 09/30/2004 | US20040191827 Modulators of the hypocretin system and methods of screening therefor |
| 09/30/2004 | US20040191820 Using high throughput assay for detection and identification of modulators of telomeric complex binding activity; diagnosis and treatment of cell proliferative and age related disorders; antiproliferative agent |
| 09/30/2004 | US20040191805 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment |
| 09/30/2004 | US20040191800 Comprises nucleotide sequences coding protein which controls thermogenesis in human skeletal muscle and heart for prevention and treatment of obesity, cachexia, cardiovascular and muscular disorders |
| 09/30/2004 | US20040191797 Human G-protein coupled receptor |
| 09/30/2004 | US20040191795 Rapid serological test for paratuberculosis using fluorescence polarization technology |
| 09/30/2004 | US20040191791 Comprises nucleotide sequences coding sodium voltage gated channels for identifying modulators for treatment of epilepsy; diagnosis of seizure disorders |
| 09/30/2004 | US20040191790 Comprises activator polypeptide which confers heat resistance and stability to polygalacturonase; identifying modulators which decrease or increase pectin degradation in fruit juices |
| 09/30/2004 | US20040191771 Candida albicans cofilin |
| 09/30/2004 | US20040191767 Comprises nucleotide sequences coding hepatitis core protein fusion for generating vaccine to prevent infcetion and treat liver dysfunction; gene therapy and cell-mediated immune response |
| 09/30/2004 | US20040191766 Using fusion protein comprised of terminal reporter molecules to detect virusbinding and entry into cells; receptor-dependent targeted therapy; viricides |
| 09/30/2004 | US20040191763 HBV mutations associated with reduced susceptibility to adefovir |
| 09/30/2004 | US20040191762 Method for purification of viral vectors having proteins which bind sialic acid |
| 09/30/2004 | US20040191761 Modified adenoviral E1A constructs and methods of use thereof |
| 09/30/2004 | US20040191335 Filtering aqueous dispersion of defatted meal and hydrolyzing with protease enzymes; producing high molecular weight retentate fraction |
| 09/30/2004 | US20040191285 Unhydrolyzed jojoba protein products having high simmondsin concentration and methods of producing the same |
| 09/30/2004 | US20040191272 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 09/30/2004 | US20040191269 Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods |
| 09/30/2004 | US20040191268 Isolated, synthetic or recombinant nonapeptide of a minor Histocompatability antigen HA-1 comprising the sequence valine-leucine-X-aspartic acid-aspartic acid-leucine-leucine-glutamic acid-alanine wherein X is arginine or histidine; bone marrow transplants; graft versus host disease; leukemia |
| 09/30/2004 | US20040191267 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof |
| 09/30/2004 | US20040191262 Isolated and purified antigen expressed by wild-type Ehrlichia risticii strain; vaccines |
| 09/30/2004 | US20040191261 Genetically engineered fusion protein comprising fibrin/fibrinogen binding moiety such as endothelial growth factor (VEGF165) C-terminal domain fused to a wound healing agent such as leptin |
| 09/30/2004 | US20040191257 Pharmaceutical compositions comprising herpes virus entry receptor protein |
| 09/30/2004 | US20040191251 Rescue of gonadotropin releasing hormone receptor mutants |
| 09/30/2004 | US20040191233 Bifidobacteria and siderophores produced thereby and methods of use |
| 09/30/2004 | US20040191230 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin |
| 09/30/2004 | US20040191223 Combinatorial methods for inducing cancer cell death |
| 09/30/2004 | US20040191222 Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby |
| 09/30/2004 | US20040191173 Metastasis models using green fluorescent protein (GFP) as a marker |
| 09/30/2004 | DE10312625A1 Method for preparing functional peptide nucleic acids, useful e.g. in gene therapy and as detection probes, using protected synthon that allows subsequent reaction with functional carboxylic acid |
| 09/30/2004 | CA2743539A1 Angiotensin-converting enzyme inhibitory peptides |
| 09/30/2004 | CA2522786A1 Gene therapy vectors having reduced immunogenicity based on cd8 alpha-chain |
| 09/30/2004 | CA2522380A1 Specific inhibition of allorejection |
| 09/30/2004 | CA2519511A1 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| 09/30/2004 | CA2519414A1 Methods of treating inflammatory diseases associated with bone destruction |
| 09/30/2004 | CA2519131A1 Ligands for tgf-beta binding proteins and uses thereof |
| 09/30/2004 | CA2519129A1 Method for detecting alzheimer's disease and corresponding peptides and detection reagents |
| 09/30/2004 | CA2519027A1 Agent comprise an albumin-like first polypeptide bound to a second polypeptide |
| 09/30/2004 | CA2518926A1 Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby |
| 09/30/2004 | CA2518924A1 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 09/30/2004 | CA2518722A1 Improved extraction process |
| 09/30/2004 | CA2517283A1 Relaxin3-gpcr135 complexes and their production and use |
| 09/30/2004 | CA2517186A1 Regulation of cell surface proteins |
| 09/30/2004 | CA2516814A1 Methods of evaluating glycomolecules for enhanced activities |
| 09/30/2004 | CA2516726A1 Amylin aggregation inhibitors and use thereof |
| 09/30/2004 | CA2513458A1 Virulent systemic feline calicivirus |
| 09/29/2004 | EP1462522A2 Maize Met-1 promoter |
| 09/29/2004 | EP1462521A1 Human p53 splice variant displaying differential transcriptional activity |
| 09/29/2004 | EP1462518A1 Adipocyte differentiation-associated gene and protein |
| 09/29/2004 | EP1462457A1 Cytotoxic protein and utilization thereof |
| 09/29/2004 | EP1462455A1 Novel peptides and medicinal uses thereof |
| 09/29/2004 | EP1462126A1 Improved Osteoinductive Materials |
| 09/29/2004 | EP1462114A1 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GRIT or TNFRSF18) |
| 09/29/2004 | EP1462112A1 Remedies for dry eye and diseases associated with dry eye |
| 09/29/2004 | EP1461620A2 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 09/29/2004 | EP1461450A1 T-bet compositions and methods of use thereof |
| 09/29/2004 | EP1461446A2 Lipid-associated molecules |
| 09/29/2004 | EP1461445A2 Glycoprotein remodeling using endoglycanases |
| 09/29/2004 | EP1461444A2 Glycopeptide remodeling using amidases |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461439A1 Method for the transformation of vegetable plastids |
| 09/29/2004 | EP1461437A2 Expression vectors and promoters for heterologous gene expression |